These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 236539)

  • 1. [Letter: Lichen eruptions after allogenic bone marrow graft].
    Saurat JH; Gluckman E; Bussel A; Didier-Jean L
    Nouv Presse Med; 1975 Mar; 4(10):745 (1). PubMed ID: 236539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of bone marrow aplasia by allogenic bone marrow grafts].
    Gluckman E; Bussel A; Benbunan M; Broquet MA; Schaison G; Dausset J; Bernard J
    Nouv Presse Med; 1975 Apr; 4(16):1177-82. PubMed ID: 240152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of mice and men in bone marrow transplantation.
    Mathé G; Schwarzenberg L; Halle-Pannenko O; Abuaf N; Pouillart P
    Transplant Proc; 1977 Mar; 9(1):155-68. PubMed ID: 17189
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and biological characteristics of lichenous eruptions after bone marrow grafts].
    Saurat JH; Gluckman E; Bonnetblanc JM; Didier-Jean L; Bussel A; Puissant A
    Ann Dermatol Syphiligr (Paris); 1975; 102(5-6):521-5. PubMed ID: 782336
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation for the treatment of severe aplastic anaemia.
    Spruce W; McMillan R; Beutler E
    Clin Haematol; 1983 Feb; 12(1):285-310. PubMed ID: 6340884
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
    Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
    J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft-versus-host disease.
    Gatti RA; Kersey JH; Yunis EJ; Good RA
    Prog Clin Pathol; 1973; 5():1-18. PubMed ID: 4150104
    [No Abstract]   [Full Text] [Related]  

  • 12. [Post-hepatitic aplasia treated by grafts of allogenic bone marrow. Remission for more than 2 years. Persistance of a total hematopoietic chimera. Graft versus host reaction].
    Rochant H; Mannoni P; Brun B; Beaujean F; Kritvitzki A; Duval J; Dreyfus B
    Nouv Presse Med; 1975 Apr; 4(16):1183-8. PubMed ID: 240153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation in DLA-haploidentical canine littermates: fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG).
    Kolb HJ; Bodenberger U; Rodt HV; Rieder I; Netzel B; Grosse-Wilde H; Scholz S; Thierfelder S
    Haematol Blood Transfus; 1980; 25():61-71. PubMed ID: 7021361
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation of xenogeneic antibodies eliminating lymphocytes from human bone marrow selectively.
    Wulff JC; Anderson M; Held H; Müller-Hermelink HK; Schlaak M; Müller-Ruchholtz W
    Transplant Proc; 1981 Mar; 13(1 Pt 1):230-3. PubMed ID: 7022829
    [No Abstract]   [Full Text] [Related]  

  • 15. [Allogenic bone marrow graft after conditioning with only antilymphocytic serum in states of bone marrow aplasias].
    Amiel JL; Mathe G; Schwarzenberg L; Schneider M; Choay J; Trolard P; Hayat M; Schlumberger JR; Jasmin C
    Presse Med (1893); 1970 Sep; 78(40):1727-34. PubMed ID: 4394378
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone-marrow transplantation in France, 1958-1973.
    Mathé G; Schwarzenberg L
    Transplant Proc; 1974 Dec; 6(4):335-43. PubMed ID: 4155150
    [No Abstract]   [Full Text] [Related]  

  • 17. Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
    Buckner CD; Clift RA; Fefer A; Lerner KG; Neiman PE; Storb R; Thomas ED
    Transplant Proc; 1974 Dec; 6(4):365-6. PubMed ID: 4612892
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antilymphocyte serum as an immunosuppressant].
    Wiig JN
    Tidsskr Nor Laegeforen; 1973 Mar; 93(9):574-8. PubMed ID: 4148532
    [No Abstract]   [Full Text] [Related]  

  • 19. Lichen-planus-like eruption following bone marrow transplantation: a manifestation of the graft-versus-host disease.
    Saurat JH; Gluckman E
    Clin Exp Dermatol; 1977 Dec; 2(4):335-44. PubMed ID: 23914
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts.
    Weiden PL; Doney K; Storb R; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):213-6. PubMed ID: 345561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.